Home » Topics » BioWorld Science

BioWorld Science
RSS

Lundbeck describes new PDE1 inhibitors

July 12, 2019

Hydra's opposite: researchers identify broad resistance mechanism to narrowly targeted therapies

July 12, 2019

CEPI and WBVR partner on vaccine for Rift Valley fever

July 12, 2019

NDFIP1 may be a novel target for prevention and treatment of Parkinson's disease

July 12, 2019

Tracer quantification and assessment of tumor uptake of [18F]afatinib in NSCLC

July 12, 2019

[89Zr]-Daratumumab as a promising new agent for CD38-targeted imaging of myeloma

July 12, 2019

mR-21 as potential prognostic biomarker and therapeutic target in hypertensive heart disease

July 12, 2019

Patient recruitment ongoing in phase I study of CPI-200

July 12, 2019

Pfizer initiates phase II study of PF-06826647 for the treatment of plaque psoriasis

July 12, 2019

Pact Pharma initiates first-in-human study of NeoTCR-P1 in solid tumors

July 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...